Heart Failure
Conference Coverage
AHA: HFpEF, HFrEF cause similar acute hospitalization rates
Key clinical point: Heart failure with preserved ejection fraction closely tracked to heart failure with reduced ejection fraction for causing U.S...
Conference Coverage
VIDEO: Monitoring helps only adherent heart failure patients
Key clinical point: Remote monitoring failed to reduce mortality or hospitalizations for all patients during the 180 days following heart failure...
Conference Coverage
AHA: Sacubitril/valsartan cuts heart failure hospital readmissions
Key clinical point: In the PARADIGM-HF pivotal trial, treating chronic heart failure with reduced ejection fraction with sacubitril/valsartan cut...
Conference Coverage
AHA: Candesartan protects against cardiotoxicity in breast cancer patients in PRADA
Candesartan prevents early decrease in LVEF during breast cancer adjuvant therapy.
News
AHA: SPRINT’s results upend hypertension targets
Key clinical point: The first full report of results from the SPRINT trial of hypertension treatment targets generated lots of opinions on their...
Conference Coverage
AHA: Mixed results for mitral valve replacement vs. repair
Mitral valve replacement reduced regurgitation better than valve repair, but it didn’t significantly improve left ventricular function or survival...
Conference Coverage
Nitrate therapy linked to less exercise in heart failure
Isosorbide mononitrate therapy may be associated with lower levels of daily activity in patients with heart failure and preserved ejection...
Conference Coverage
VIDEO: HFSA Roundtable, part 3: Acute heart failure decompensations pose uncertain consequences
Acute decompensation episodes in chronic heart failure patients have an uncertain relationship with long-term prognosis
Conference Coverage
VIDEO: HFSA Roundtable, part 2: Prevention offers best HFpEF strategy
Heart failure with preserved ejection fraction reflects premature aging of the vasculature and myocardium that is best managed by prevention.
News
AHA releases first-ever pediatric pulmonary hypertension guideline
Conference Coverage
HFSA Roundtable, part 1: Beta-blockers remain heart failure management linchpin
Beta-blockers remain a key part of treatment for chronic heart failure, and control of neurohormonal activation remains a central principle of...